Modeling and interactions analysis of the novel antagonist agent flibanserin with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor as a HSDD treatment in premenopausal women
Journal: Iranian Chemical Communication (Vol.7, No. 3)Publication Date: 2019-05-01
Authors : Mehdi Nabati;
Page : 324-334
Keywords : Flibanserin; HSDD; Molecular docking; molecular simulation; premenopausal women;
Abstract
Flibanserin is a novel antagonist small molecule to treat the hypoactive sexual desire disorder (HSDD) in the premenopausal women. The present article is related to the structural and electronic properties study and docking analysis of the title compound with 5-hydroxytryptamine 2A (5-HT2A) serotonin receptor. To access these aims, the molecular structure of the said compound was optimized using density functional theory (DFT) computational method (B3LYP) with 6-31+G(d,p) basis set at room temperature. In continuous, the frontier molecular orbitals (FMOs) theory used to investigate the stability and reactivity of flibanserin. The mentioned studies showed that the molecule under investigation is a compound with high stability. The docking analysis was used to understand the nature of receptor-ligand interactions. Our study indicated that the steric interactions play main role in ligand-receptor complex formation.
Other Latest Articles
- The use of topological indices to predict thermodynamic properties of amino acids derivatives
- 4-Aryl-2, 6-di(pyren-1-yl)pyridines: A facile procedure for synthesis and studying of fluorescence properties
- Catalytic application of 3-methyl-1-sulfonic acid imidazolium tetrachloroferrate as nanostructured catalyst on the cross-aldol condensation reaction of cycloalkanones with aldehydes
- A simplified green approach for synthesis of arylquinoxalines under solvent-free clay-catalysed conditions
- Nanomagnetic organic-inorganic hybrid (CuFe2O4@Si-Imid-PMo): an efficient green catalyst for the synthesis of 2,4,5-trisubstituted imidazoles
Last modified: 2019-06-26 14:30:31